A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma

Clinical trial NCT02110355 · COMPLETED

Trial details

NCT number: NCT02110355
Sponsor: Kartos Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy Advanced Solid Tumors Cancer Oncology Oncology Patients Tumors Melanoma

Start date: 2014-12-19
Primary completion: 2018-12-27
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.